Long-acting therapeutic delivery systems for the treatment of gliomas

S Padmakumar, MM Amiji - Advanced Drug Delivery Reviews, 2023 - Elsevier
Despite the emergence of cutting-edge therapeutic strategies and tremendous progress in
research, a complete cure of glioma remains elusive. The heterogenous nature of tumor …

Nucleic acid therapies for CNS diseases: pathophysiology, targets, barriers, and delivery strategies

S Padmakumar, A D'Souza, NN Parayath… - Journal of Controlled …, 2022 - Elsevier
Nucleic acid therapeutics have emerged as one of the very advanced and efficacious
treatment approaches for debilitating health conditions, including those diseases affecting …

[HTML][HTML] Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets

S Padmakumar, P Kulkarni, CF Ferris, BS Bleier… - Biomedicine & …, 2022 - Elsevier
The clinical translation of therapeutic approaches to combat debilitating neurodegenerative
conditions, such as Parkinson's disease (PD), remains as an urgent unmet challenge. The …

Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting

C Marianecci, F Rinaldi, PN Hanieh… - Drug design …, 2017 - Taylor & Francis
The blood–brain barrier (BBB) plays a fundamental role in protecting and maintaining the
homeostasis of the brain. For this reason, drug delivery to the brain is much more difficult …

Ultrasound combined with glial cell line-derived neurotrophic factor-loaded microbubbles for the targeted treatment of drug addiction

F Wang, H Wu, A Hu, L Dong, X Lin, M Li… - … in Bioengineering and …, 2022 - frontiersin.org
Drug addiction is a serious problem globally, recently exacerbated by the COVID-19
pandemic. Glial cell-derived neurotrophic factor (GDNF) is considered a potentially effective …

Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases

S Padmakumar, MS Taha, E Kadakia… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Neurodegenerative diseases are those wherein the neurons in the brain or
peripheral nervous system lose their function, eventually culminating in neuronal death …

From designing the molecules of life to designing life: future applications derived from advances in DNA technologies

RE Kohman, AM Kunjapur, E Hysolli… - Angewandte Chemie …, 2018 - Wiley Online Library
Since the elucidation of its structure, DNA has been at the forefront of biological research. In
the past half century, an explosion of DNA‐based technology development has occurred …

Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting

GN Pawar, NN Parayath, AL Nocera, BS Bleier… - PLoS …, 2018 - journals.plos.org
Delivering therapeutics across the blood-brain barrier (BBB) for treating central nervous
system (CNS) diseases is one of the biggest challenges today as the BBB limits the uptake …

Harnessing stem cells and neurotrophic factors with novel technologies in the treatment of Parkinson's disease

M Conese, R Cassano, E Gavini… - Current Stem Cell …, 2019 - ingentaconnect.com
Parkinson's disease (PD) is characterized by loss of dopaminergic neurons, oxidative stress
and neuroinflammation. The classical therapeutic approach with L-DOPA is not able to …

Nasal delivery of nanotherapeutics for CNS diseases: challenges and opportunities

AA D'Souza, S Kutlehria, D Huang, BS Bleier… - …, 2021 - Taylor & Francis
CNS disorders represent neurological disorders that affect either the structure or function of
the brain or spinal cord. CNS diseases include Alzheimer's disease, Parkinson's disease …